Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention.

Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention. Can J Cardiol. 2022 06; 38(6):792-800.

View in: PubMed

subject areas

C-Reactive Protein
Diabetes Mellitus
Humans
Inflammation
Myocardial Infarction
Percutaneous Coronary Intervention
Prognosis
Risk Factors
Treatment Outcome

authors with profiles

Usman Baber